We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Generics company Mylan along with Biocon Biologics launched their diabetes drug Semglee, a version of Lantus, this week, touting it as 65 percent less expensive than other long-acting insulin products on the market. Read More
Nestlé has announced that it will acquire Aimmune Therapeutics for $2.6 billion in a deal that will add Palforzia — the first FDA-approved treatment for patients with peanut allergy — to Nestlé’s pharmaceuticals portfolio. Read More
The Massachusetts-based drugmaker is also in discussions with the European Commission to supply 80 million doses of the vaccine to the European Union. Read More
Moderna said Friday that it is in talks with Japan’s Ministry of Health, Labor and Welfare to supply the country with at least 40 million doses of its COVID-19 vaccine. Read More
The contract also allows for vaccine doses to be donated to low- and middle-income countries, and for member states to re-direct vaccines to other European countries. Read More
The European Commission is ramping up its efforts to obtain COVID-19 vaccines for EU member states. The commission and AstraZeneca (AZ) signed a contract yesterday for the drugmaker to supply up to 400 million COVID-19 vaccine doses for the EU. Read More